Advisory Alpha’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
3,508
+204
+6% +$86.2K 0.03% 179
2026
Q1
$1.56M Buy
3,304
+423
+15% +$213K 0.04% 143
2025
Q4
$1.35M Buy
2,881
+318
+12% +$148K 0.04% 158
2025
Q3
$1.09M Buy
2,563
+600
+31% +$233K 0.03% 168
2025
Q2
$752K Buy
1,963
+371
+23% +$134K 0.02% 206
2025
Q1
$550K Buy
1,592
+474
+42% +$152K 0.02% 234
2024
Q4
$336K Buy
1,118
+140
+14% +$48.9K 0.01% 297
2024
Q3
$398K Buy
978
+29
+3% +$10.6K 0.01% 268
2024
Q2
$305K Buy
949
+340
+56% +$110K 0.01% 288
2024
Q1
$203K Buy
+609
New +$186K 0.01% 376
2020
Q4
Sell
-31
Closed -$4K 323
2020
Q3
$4K Buy
+31
New +$3.84K ﹤0.01% 542
2020
Q2
Sell
-31
Closed -$3.25K 307
2020
Q1
$3.25K Hold
31
﹤0.01% 550
2019
Q4
$4.56K Sell
31
-9
-23% -$1.21K ﹤0.01% 586
2019
Q3
$4.7K Buy
+40
New +$5.17K ﹤0.01% 549
2019
Q2
Sell
-31
Closed -$3.86K 335
2019
Q1
$3.86K Buy
+31
New +$4.16K ﹤0.01% 490

Other funds holding HCA

Advisory Alpha's HCA Position: Q2 2026 in Review

Advisory Alpha increased its HCA Healthcare (HCA) stake by 6.2% in Q2 2026, buying an estimated $86.2K and bringing the position to 3,508 shares worth $1.37M. The position accounts for 0.03% of the portfolio, ranked #179.

Advisory Alpha first reported a position in HCA in Q1 2019 and has held it in 15 quarters since. The position peaked at $1.56M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Advisory Alpha held 3,508 shares of HCA Healthcare worth $1.37M as of Q2 2026.
  • Advisory Alpha bought 204 HCA Healthcare shares in Q2 2026, an estimated $86.2K.
  • HCA Healthcare made up 0.03% of Advisory Alpha's portfolio in Q2 2026, its #179 holding.
  • Advisory Alpha first reported a position in HCA Healthcare in Q1 2019 and has held it in 15 quarters since.
  • Advisory Alpha's HCA Healthcare position peaked at $1.56M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.